Exploring COVID-19 vaccine adverse events among pregnant women: a cross-sectional study, 2022

Faculty Medicine Year: 2024
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Therapeutic Advances in Vaccines and Immunotherapy Saga Volume:
Keywords : Exploring COVID-19 vaccine adverse events among    
Abstract:
Clear and trustworthy information is crucial to improving public acceptance of COVID-19 vaccinations, especially among pregnant women. Given the increased risk of severe viral pneumonia in pregnant women, it is critical to foster confidence in the vaccine’s safety and understand any potential adverse events (AEs). So, we did this study in Jeddah, Saudi Arabia (SA), from March to May 2022 to compare women who did not get any doses of the COVID-19 vaccine during pregnancy (Group A) to women who did get at least one dose during pregnancy (Group B) regarding (1) the frequency, types, AEs, and management of its AEs of the COVID-19 vaccination; and (2) exploring pregnancy, delivery, and fetus-related complications (e.g., miscarriage, birth defects, and preterm labor) Methods: A cross-sectional study targeted 438 women who gave birth or were pregnant within the previous 8 weeks. Data was collected through face-to-face interviews with skilled nurses in 13 randomly selected primary healthcare facilities, using a validated, well-structured questionnaire that included the Centers for Disease Control (CDC) COVID-19 vaccination-related AEs. We analyzed the collected data using SPSS version 27. Results: Most participants were aged 25 to less than 35 (58.8%), and 287 (61.3%) were university graduates. There was no statistically significant difference among the studied groups regarding demographics. However, women in Group B had a significantly higher rate of abortions, oligohydramnios (24.4%), abnormal placentas (size and location), 103 (42.7%) abnormal fetal growth, 122 (53.7%) problems breastfeeding, blood pressure problems, and more cases of malaise, headaches, chest pain, breathing problems, and sleep problems than women in Group A. After the second and third doses, the confirmed post-vaccination COVID-19 rates in Group B were lower than those in Group A. Conclusion: The COVID-19 vaccine significantly reduces post-vaccination COVID-19. Although COVID-19 vaccine-related AES are prevalent, analgesics and antipyretics effectively treat most of them
   
     
 
       

Author Related Publications

  • Samar Ahmed Ahmed Amer, "ASSESSMENT OF SOME APPROACHES FOR WEIGHT REDUCTION AMONG ADULT FEMALES;AN INTERVENTIONAL STUDY AT ZAGAZIG UNIVERSITY HOSPITAL", Z.U.M.J.Vol.20; N.2, 2014 More
  • Samar Ahmed Ahmed Amer, "Study of p16 promoter methylation in Egyptian colorectal cancer patients", wiley, 2019 More
  • Samar Ahmed Ahmed Amer, "Prevalence and Determinants of Mobile Health Applications Usage: A National Descriptive Study", Frontiers, 2022 More
  • Samar Ahmed Ahmed Amer, "The prevalence of undiagnosed attentiondeficit/hyperactivity disorder among undergraduate medical students: a survey from Pakistan", Springer, 2024 More
  • Samar Ahmed Ahmed Amer, "Fear of COVID-19, Stress and Coping Strategies among Nurses during the COVID-19 Pandemic’s Second Wave: A Quasi-Intervention Study", Bentham Science Publishers B.V, 2022 More

Department Related Publications

  • Ibrahim Ghareeb Mohamed Ahmed, "تركيز هرمون البرولاكتين فى الحبل السري فى الحمل العادى والغير سرى ", لايوجد, 1900 More
  • Ibrahim Ghareeb Mohamed Ahmed, "المنظار الضوئي الرحمي والمبيض المهبلي فى تشخيص العوامل الرحمية حالات تكرار فقدان الجنين", لايوجد, 1900 More
  • Ahmed Ahmed Mohamed Ameir, "استخدام منظار البطن فى حالات اشتباة التهاب الزائدة الدوريه الحاد عند السيدات.", لايوجد, 1900 More
  • Ahmed Ahmed Mohamed Ameir, "اثر تلوث البيئة على مستويات الرصاص فى دم المهات والأطفال حديثى الولادة بمحافظة الشرقية.", لايوجد, 1900 More
  • Ahmed Ahmed Mohamed Ameir, "كيس المسح بالموجات فوق الصوتية فى المهبل كطريقة لتوقيع نتائج الحمل.", لايوجد, 1900 More
Tweet